Terray's Jacob Berlin on The AI-Powered Future of Medicine

Terray Therapeutics CEO Jacob Berlin returns to Founded & Funded after three years to share how the company has scaled from an ambitious startup to an industry leader in AI-driven biotech. Learn how Terray's proprietary hardware combined with the world's largest chemistry data set is powering new discoveries in small molecule drug development.  Jacob also discusses how the company's $120M Series B fundraise will prepare their internal programs for clinical trials and further enhance their AI platform. He shares insights on where he sees the future of AI and drug design and dives into how founders can balance internal innovation and high-profile partnerships. Don't miss this deep dive into the intersection of AI, biotech, and innovation! Transcript: https://www.madrona.com/terray-jacob-berlin-on-the-ai-powered-future-of-medicine Chapters: (00:00) Introduction 00:39 The Evolution of Terray Therapeutics (02:08) Understanding Small Molecule Therapies (04:12) The Journey of Data and AI (07:58) Series B Fundraise and Future Plans (11:20) Biotech Platform vs. Product Debate (14:20) Building a Long-Term Vision (16:39) Deep Dive into Terray's AI and Science (36:05) The Importance of Partnerships (39:20) High-Performance Culture at Terray